メインコンテンツにスキップ
検索

後期臨床

登録

最新のリソース

注目コンテンツ

Upcoming late clinical webinars

Latest late clinical blogs

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

SCDM US Annual Conference 2026

September 14 - 17, 2026
対面セミナー・イベント

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

2026年9月21日 – Cambridge Innovation Center (CIC), 1 Broadway, 5th Floor, Havana Room | Cambridge, MA
展示会・学会

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD

All late clinical resources

Population Dose-response Analysis of Daily Seizure Count Following Vigabatrin Therapy in Adult and Pediatric Patients with Refractory Complex Partial Seizures

Central Nervous System (CNS), Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

Pharmacokinetics of Injectable, Long-acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants

Infectious Disease, Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Publication

Onartuzumab with or without Bevacizumab in Combination with Weekly Paclitaxel Does Not Prolong QTc or Adversely Affect Other ECG Parameters in Patients with Locally Recurrent or Metastatic Triple-negative Breast Cancer

Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, pre-update, Therapeutic Specialties, Publication

Pharmacokinetics of Vancomycin in Critically Ill Patients in Thailand

Clinical Trials, Infectious Disease, Modeling and Simulation - PK/PD, pre-update, Publication

Meropenem in Children Receiving Continuous Renal Replacement Therapy: Clinical Trial Simulations Using Realistic Covariates

Clinical Trials, Infectious Disease, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pediatrics, pre-update, Therapeutic Specialties, Publication

Vigabatrin Pediatric Dosing Information for Refractory Complex Partial Seizures: Results from a Population Dose-response Analysis

Central Nervous System (CNS), Model Informed Drug Development, Modeling and Simulation - PK/PD, Pediatrics, pre-update, Therapeutic Specialties, Publication

Modeling and Simulation for Medical Product Development and Evaluation: Highlights from the FDA-C-Path-ISOP 2013 Workshop

Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Publication

Population Pharmacokinetics Analysis of Vigabatrin in Adults and Children with Epilepsy and Children with Infantile Spasms

Central Nervous System (CNS), Model Informed Drug Development, Modeling and Simulation - PK/PD, Pediatrics, pre-update, Therapeutic Specialties, Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir Against Chronic HCV

Infectious Disease, Modeling and Simulation - PK/PD, pre-update, Publication

The Rise of Systems Pharmacology in Drug Discovery and Development

Model Informed Drug Development, Modeling and Simulation - QSP, pre-update, Publication

Time Course of Bone Mineral Density Changes with Denosumab Compared with Other Drugs in Postmenopausal Osteoporosis: A Dose-response-based Meta-analysis

Certara Services, Model Informed Drug Development, Modeling and Simulation - MBMA, Modeling and Simulation - PK/PD, pre-update, Publication

Development of Physiologically-based Pharmacokinetic Model to Evaluate the Relative Systemic Exposure to Quetiapine After Administration of IR and XR Formulations to Adults, Children, and Adolescents

Central Nervous System (CNS), Model Informed Drug Development, Pediatrics, pre-update, Therapeutic Specialties, Publication
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software